| P50 | author | Roberto Cusano | Q116782346 |
| | Sandro Orru | Q42757395 |
| P2093 | author name string | Antonello Pani | |
| | Carlo Carcassi | |
| | Maurizio Melis | |
| | Davide Argiolas | |
| | Donatella Valentini | |
| | Elena Congeddu | |
| | Elisabetta Carta | |
| | Francesco Alba | |
| | Gianbenedetto Piredda | |
| | Giorgio La Nasa | |
| | Giovanni Caocci | |
| | Luisella Cappai | |
| | Marcella Arras | |
| | Maria Benigna Michittu | |
| | Maria Serra | |
| | Mauro Frongia | |
| | Paola Ragatzu | |
| | Rita Porcella | |
| | Roberta Maddi | |
| | Roberto Littera | |
| | Sara Lai | |
| | Valentina Loi | |
| P2860 | cites work | Cross-Allele Cytotoxic T Lymphocyte Responses against 2009 Pandemic H1N1 Influenza A Virus among HLA-A24 and HLA-A3 Supertype-Positive Individuals | Q27673689 |
| | Human diversity in killer cell inhibitory receptor genes | Q28259075 |
| | Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1 | Q28277389 |
| | HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1 | Q28278705 |
| | Up on the tightrope: natural killer cell activation and inhibition | Q29619175 |
| | Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants | Q29619458 |
| | Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity | Q33378871 |
| | CD28(-) T cells: their role in the age-associated decline of immune function | Q33572405 |
| | Does the KIR2DS5 gene protect from some human diseases? | Q33701536 |
| | HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses. | Q33755226 |
| | KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation | Q34017594 |
| | HLA compatibility and organ transplant survival. Collaborative Transplant Study. | Q34188342 |
| | Ligands for natural killer cell receptors: redundancy or specificity | Q34341435 |
| | Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation. | Q34427302 |
| | Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules | Q35701077 |
| | Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. | Q35850712 |
| | MHC class I molecules and KIRs in human history, health and survival | Q36047157 |
| | Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function | Q36228467 |
| | CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells | Q36352518 |
| | HLA alleles determine differences in human natural killer cell responsiveness and potency | Q36498481 |
| | The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense | Q36528852 |
| | Kidney transplantation: mechanisms of rejection and acceptance | Q37014859 |
| | Recent developments in kidney transplantation--a critical assessment | Q37301840 |
| | Killer Ig–like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation | Q37796492 |
| | Rejection of the kidney allograft | Q37798268 |
| | The specificity of acute and chronic microvascular alterations in renal allografts | Q38151921 |
| | Natural killer-cell activity after human renal transplantation in relation to killer immunoglobulin-like receptors and human leukocyte antigen mismatch1 | Q59624577 |
| | Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system | Q69887780 |
| | Natural killer cells in renal allograft rejection | Q70394064 |
| | Relevance of KIR gene polymorphisms in bone marrow transplantation outcome | Q74209558 |
| | KIR/HLA ligand incompatibility in kidney transplantation | Q80228070 |
| | Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients | Q81471281 |
| | KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation | Q84468930 |
| | Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients | Q86054333 |
| | Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation | Q86063263 |
| | A new HLA allocation procedure of kidneys from deceased donors in the current era of immunosuppression | Q86925335 |
| | Distribution of killer cell immunoglobulin-like receptors genes in the Italian Caucasian population. | Q39085743 |
| | Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. | Q39904553 |
| | Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients | Q40608260 |
| | KIR2DL4 Is an IL-2-Regulated NK Cell Receptor That Exhibits Limited Expression in Humans but Triggers Strong IFN-γ Production | Q40633231 |
| | Interleukin-15, a leukocyte activator and growth factor, is produced by cortical tubular epithelial cells | Q41030242 |
| | Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. | Q41731150 |
| | Rapid increase of interleukin-10 plasma levels after combined auxiliary liver-kidney transplantation in presensitized patients | Q42225499 |
| | Rapamycin and MPA, but not CsA, impair human NK cell cytotoxicity due to differential effects on NK cell phenotype | Q42872856 |
| | Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules. | Q43887085 |
| | Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. | Q44077392 |
| | No impact of KIR-ligand mismatch on allograft outcome in HLA-compatible kidney transplantation | Q44526861 |
| | Immunologic diagnosis of kidney rejection using FACS analysis of graft-infiltrating functional and activated T and NK cell subsets | Q45160264 |
| | Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells | Q45730372 |
| | CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation. | Q51970074 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0180831 | |
| P577 | publication date | 2017-07-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation | |
| P478 | volume | 12 | |